|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 76.01 EUR | -1.34% |
|
+3.39% | -8.11% |
| 06-10 | European Stocks Close Mixed in Wednesday Trading; Bank, Automotive Stocks Slump | MT |
| 06-10 | European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading | MT |
Company Valuation: Sanofi
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 111,194 | 112,665 | 112,549 | 116,968 | 100,655 | 91,229 | - | - |
| Change | - | 1.32% | -0.1% | 3.93% | -13.95% | -9.36% | - | - |
| Enterprise Value (EV) 1 | 121,177 | 119,102 | 120,342 | 125,740 | 111,663 | 103,262 | 101,196 | 99,839 |
| Change | - | -1.71% | 1.04% | 4.49% | -11.2% | -7.52% | -2% | -1.34% |
| P/E ratio | 17.8x | 16.7x | 20.8x | 20.4x | 12.9x | 11.3x | 10.6x | 9.12x |
| PBR | 1.62x | 1.5x | 1.52x | 1.51x | 1.41x | 1.22x | 1.16x | 1.1x |
| PEG | - | 2.07x | -1.1x | 3.14x | 0.3x | 2.34x | 1.47x | 0.6x |
| Capitalization / Revenue | 2.94x | 2.62x | 2.61x | 2.85x | 2.31x | 1.94x | 1.83x | 1.74x |
| EV / Revenue | 3.21x | 2.77x | 2.79x | 3.06x | 2.56x | 2.19x | 2.03x | 1.9x |
| EV / EBITDA | 9.95x | 8.14x | 8.44x | 9.76x | 8.22x | 7.09x | 6.56x | 5.91x |
| EV / EBIT | 11.3x | 9.13x | 9.5x | 11.1x | 9.19x | 8.05x | 7.4x | 6.65x |
| EV / FCF | 15x | 14x | 14.2x | 21.1x | 13.8x | 12x | 11.1x | 9.74x |
| FCF Yield | 6.68% | 7.12% | 7.04% | 4.74% | 7.24% | 8.32% | 9.03% | 10.3% |
| Dividend per Share 2 | 3.33 | 3.56 | 3.76 | 3.92 | 4.12 | 4.254 | 4.505 | 4.829 |
| Rate of return | 3.76% | 3.96% | 4.19% | 4.18% | 4.98% | 5.6% | 5.93% | 6.35% |
| EPS 2 | 4.97 | 5.37 | 4.31 | 4.59 | 6.4 | 6.709 | 7.193 | 8.33 |
| Distribution rate | 67% | 66.3% | 87.2% | 85.4% | 64.4% | 63.4% | 62.6% | 58% |
| Net sales 1 | 37,761 | 42,997 | 43,070 | 41,081 | 43,626 | 47,045 | 49,942 | 52,421 |
| EBITDA 1 | 12,183 | 14,627 | 14,259 | 12,889 | 13,583 | 14,559 | 15,431 | 16,882 |
| EBIT 1 | 10,714 | 13,040 | 12,670 | 11,343 | 12,149 | 12,826 | 13,680 | 15,023 |
| Net income 1 | 6,223 | 6,720 | 5,400 | 5,744 | 7,813 | 8,134 | 8,935 | 10,336 |
| Net Debt 1 | 9,983 | 6,437 | 7,793 | 8,772 | 11,008 | 12,033 | 9,967 | 8,610 |
| Reference price 2 | 88.58 | 89.84 | 89.76 | 93.74 | 82.72 | 76.01 | 76.01 | 76.01 |
| Nbr of stocks (in thousands) | 1,255,293 | 1,254,060 | 1,253,891 | 1,247,793 | 1,216,810 | 1,200,220 | - | - |
| Announcement Date | 04/02/22 | 03/02/23 | 01/02/24 | 30/01/25 | 29/01/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E ratio, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 11.26x | 2.23x | 7.27x | 5.56% | 107B | ||
| 33.49x | 12.17x | 25.07x | 0.6% | 1,021B | ||
| 25.33x | 5.84x | 15.88x | 2.25% | 571B | ||
| 27.6x | 6.73x | 13.74x | 3.04% | 398B | ||
| 17.1x | 4.23x | 10.39x | 3.14% | 319B | ||
| 23x | 4.78x | 13.59x | 1.83% | 283B | ||
| 20.62x | 5.33x | 12.95x | 3.06% | 272B | ||
| 22.4x | 6.01x | 10.5x | 2.93% | 186B | ||
| 11.92x | 4.49x | 9.18x | 4.21% | 185B | ||
| -44.91x | 5.43x | 30.64x | 2.59% | 156B | ||
| Average | 14.78x | 5.72x | 14.92x | 2.92% | 349.68B | |
| Weighted average by Cap. | 22.24x | 7.33x | 17.16x | 2.22% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- SAN Stock
- Valuation Sanofi
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















